Intrinsic Value of S&P & Nasdaq Contact Us

PDS Biotechnology Corporation PDSB NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
50/100
2/6 Pass
SharesGrow Intrinsic Value
$476,876.00
+44988201.9%
Analyst Price Target
$9.00
+749.1%

Stock Statistics — PDSB

PDS Biotechnology Corporation (PDSB) has a market capitalization of $59.16M and trades at $1.06. The 52-week range is 0.507-1.915.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.4, Earnings Per Share (EPS) of $-0.74.

The stock has a beta of 1.19, operates in the Healthcare sector.

Trading Data
Current Price$1.06
52-Week Range0.507-1.915
Volume498.15K
Avg Volume (30D)645.99K
Market Cap$59.16M
Beta (1Y)1.19
Company
IPO Date2015-09-30
Employees24
CEOFrank K. Bedu-Addo
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS70465T1079
CUSIP70465T107
Income (Latest Year)
EBITDA$-30.3M
Operating Income$-31.54B
Net Income$-36.84M
EPS$-0.74
EPS Diluted$-0.74
Shares Outstanding$46.38M
Balance Sheet (Latest Year)
Total Assets$30.49M
Current Assets$26.71M
Cash & ST Investments$26.71M
Total Liabilities$21.24M
Total Debt$5.19B
Net Debt$5.17B
Total Equity$9.25M
Debt / Equity561.21
Valuation Ratios
P/E Ratio-1.4
P/B Ratio6.39
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message